Dautzenberg MD - Search Results

1

[Antiphospholipid antibodies, thrombosis and lupus disease. Value of the assay of anticardiolipin antibodies by the ELISA technic].

Meyer O, Cyna L, Borda-Iriarte O, Jungers P, Piette JC, Dautzenberg MD, Dupuy E, Ryckewaert A. Meyer O, et al. Among authors: dautzenberg md. Rev Rhum Mal Osteoartic. 1985 May;52(5):297-305. Rev Rhum Mal Osteoartic. 1985. PMID: 3874416 French.

2

Recurrent thrombosis and lupus anticoagulant in systemic lupus erythematosus.

Lioté F, Hannedouche T, Meyer O, Dautzenberg MD, Jungers P. Lioté F, et al. Among authors: dautzenberg md. Arch Intern Med. 1986 Jun;146(6):1247. doi: 10.1001/archinte.1986.00360180267066. Arch Intern Med. 1986. PMID: 3087308 No abstract available.

3

Lupus anticoagulant and thrombosis in systemic lupus erythematosus.

Jungers P, Liote F, Dautzenberg MD, Gazengel C, Dougados M, Tron F, Bach JF. Jungers P, et al. Among authors: dautzenberg md. Lancet. 1984 Mar 10;1(8376):574-5. doi: 10.1016/s0140-6736(84)90982-6. Lancet. 1984. PMID: 6142298 No abstract available.

4

Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.

Ganeval D, Fischer AM, Barre J, Pertuiset N, Dautzenberg MD, Jungers P, Houin G. Ganeval D, et al. Among authors: dautzenberg md. Clin Nephrol. 1986 Feb;25(2):75-80. Clin Nephrol. 1986. PMID: 3698349

5

Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates.

Gazengel C, Fischer AM, Schlegel N, Rothschild C, Torchet MF, Dautzenberg MD, Aujard Y. Gazengel C, et al. Among authors: dautzenberg md. Nouv Rev Fr Hematol (1978). 1988;30(4):225-7. Nouv Rev Fr Hematol (1978). 1988. PMID: 3143100

6

[Adenoidectomy and tonsillectomy in children with hemophilia and von Willebrand disease].

Thach-Toan, Gazengel C, François M, Torchet MF, Dautzenberg MD, Roulleau P. Thach-Toan, et al. Among authors: dautzenberg md. Ann Otolaryngol Chir Cervicofac. 1985;102(6):449-56. Ann Otolaryngol Chir Cervicofac. 1985. PMID: 3879138 French.

7

Comparative effect of heparin and heparan sulphate on two abnormal antithrombin III type 3 variants.

Fischer AM, Beguin S, Sternberg C, Dautzenberg MD. Fischer AM, et al. Among authors: dautzenberg md. Br J Haematol. 1987 Jun;66(2):213-7. doi: 10.1111/j.1365-2141.1987.tb01301.x. Br J Haematol. 1987. PMID: 2955807

8

[Prevention of thrombosis by Hemoclar. Preliminary results of a test in a patient with antithrombin III deficiency].

Fischer AM, Aurousseau MH, Dautzenberg MD, Bentata-Pessayre M, Beguin S. Fischer AM, et al. Among authors: dautzenberg md. Rev Fr Transfus Immunohematol. 1982 Jun;25(3):265-72. doi: 10.1016/s0338-4535(82)80012-3. Rev Fr Transfus Immunohematol. 1982. PMID: 6180463 French.

9

Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients.

Fischer AM, Dautzenberg MD, Aurousseau MH, Béguin S, Goudemand J, Hemker HC. Fischer AM, et al. Among authors: dautzenberg md. Thromb Res. 1985 Jan 15;37(2):295-307. doi: 10.1016/0049-3848(85)90018-0. Thromb Res. 1985. PMID: 2579452

10

Antithrombin III Alger: a new homozygous AT III variant.

Fischer AM, Cornu P, Sternberg C, Mériane F, Dautzenberg MD, Chafa O, Beguin S, Desnos M. Fischer AM, et al. Among authors: dautzenberg md. Thromb Haemost. 1986 Apr 30;55(2):218-21. Thromb Haemost. 1986. PMID: 3715788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters